$2.25
0.010.45%
最終更新: Oct 19, 9:25 AM
$2.25
0.010.45%
Benzinga
Benzinga
Benzinga
月曜日, 10 19
Benzinga
© 2026 Benzinga | All Rights Reserved
CervoMed (CRVO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.87 | $-0.81 | $-0.69 | $-0.61 |
| Actual | $-0.64 | $-0.86 | $-0.88 | $-0.84 |
| Surprise | +26.4% | -6.17% | -27.5% | -37.7% |
| Revenue | ||||
| Estimate | $140000 | $90000 | $329998 | $1.1M |
| Actual | $0 | $0 | $8.7M | $322569 |
| Surprise | -100.0% | -100.0% | +2544.3% | -71.7% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.52 | $-0.49 | $-0.62 | $-0.39 |
| Revenue | ||||
| Consensus | $100000 | $166664 | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $-0.64 | $-0.87 | 26.4 % |
| Q1 | May 15, 2026 | $-0.86 | $-0.81 | -6.17 % |
| Q4 | Mar 17, 2026 | $-0.88 | $-0.69 | -27.5 % |
| Q3 | Nov 10, 2025 | $-0.84 | $-0.61 | -37.7 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $0 | $140.00K | -100.0 % |
| Q1 | May 15, 2026 | $0 | $90.00K | -100.0 % |
| Q4 | Mar 17, 2026 | $8.73M | $330.00K | 2544.3 % |
| Q3 | Nov 10, 2025 | $322.57K | $1.14M | -71.7 % |